Inovio Pharmaceuticals, Inc. (BMV:INO)

Inovio Pharmaceuticals Revenue

Inovio Pharmaceuticals had revenue of $182.34K USD in the twelve months ending June 30, 2025, down -69.19% year-over-year. In the year 2024, Inovio Pharmaceuticals had annual revenue of $217.76K, down -73.83%.

• Revenue (ttm): $182.34K
• Revenue Growth: -69.19%
• P/S Ratio: 736.62
• Revenue / Employee: $1.36K
• Employees: 134
• Market Cap: 2.53B MXN

Revenue Chart

* This company reports financials in USD.

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	217.76K	-614.25K	-73.83%
Dec 31, 2023	832.01K	-9.43M	-91.89%
Dec 31, 2022	10.26M	8.49M	478.23%
Dec 31, 2021	1.77M	-5.64M	-76.05%
Dec 31, 2020	7.41M	-812.64K	-9.88%
Dec 31, 2019	8.22M	-52.74M	-86.51%
Dec 31, 2018	60.96M	-23.48M	-27.80%
Dec 31, 2017	84.44M	13.70M	19.37%
Dec 31, 2016	70.74M	-10.41M	-12.83%
Dec 31, 2015	81.14M	60.23M	288.00%
Dec 31, 2014	20.91M	-6.02M	-22.35%
Dec 31, 2013	26.93M	18.70M	226.98%
Dec 31, 2012	8.24M	-11.35M	-57.95%
Dec 31, 2011	19.59M	7.30M	59.41%
Dec 31, 2010	12.29M	-5.95M	-32.62%
Dec 31, 2009	18.24M	14.04M	334.78%
Dec 31, 2008	4.20M	-5.42M	-56.37%
Dec 31, 2007	9.62M	2.68M	38.62%
Dec 31, 2006	6.94M	-4.00M	-36.56%
Dec 31, 2005	10.93M	-	-